Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis

Cancer Research

Volumn 71, Issue 24, 2011, Pages 7502-7512

  Aoi, Jun ^a   Endo, Motoyoshi ^a   Kadomatsu, Tsuyoshi ^a   Miyata, Keishi ^a   Nakano, Masahiro ^a   Horiguchi, Haruki ^a   Ogata, Aki ^a   Odagiri, Haruki ^a   Yano, Masato ^a   Araki, Kimi ^a   Jinnin, Masatoshi ^a   Ito, Takaaki ^b   Hirakawa, Satoshi ^c   Ihn, Hironobu ^a   Oike, Yuichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CANCER TISSUE; CHEMICAL CARCINOGENESIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; KNOCKOUT MOUSE; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN EPITHELIUM; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TRANSGENIC MOUSE; TUMOR VASCULARIZATION; WILD TYPE;

ANGIOPOIETINS; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHANGIOGENESIS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 84255192073     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1758     Document Type: Article

References (29)

1. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008;359:2814-23.
2. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
3. de Martel C, Franceschi S. Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 2009;70:183-94.
4. Takahashi H, Takahashi I, Honma M, Ishida-Yamamoto A, Iizuka H. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci 2010;57:143-4.
5. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008;320:674-7. (Pubitemid 351928351)
6. Kant P, Hull MA. Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 2011;8:224-38.
7. Calle EE. Obesity and cancer. BMJ 2007;335:1107-8. (Pubitemid 350247271)
8. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010;140:197-208.
9. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009;10:178-88.
10. Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005;24:3470-81. (Pubitemid 41486784)
11. Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009;15:21-34.
12. Okada T, Tsukano H, Endo M, Tabata M, Miyata K, Kadomatsu T, et al. Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 2010;176:2309-19.
13. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008;8:604-17.
14. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10:9-22.
15. Kikuchi R, Tsuda H, Kozaki K, Kanai Y, Kasamatsu T, Sengoku K, et al. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Cancer Res 2008;68:5067-75.
16. Yuspa SH, Døugosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB, et al. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J Invest Dermatol. 1994;103:90S-5S. (Pubitemid 24348781)
17. Hawighorst T, Velasco P, Streit M, Hong YK, Kyriakides TR, Brown LF, et al. Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J 2001;20:2631-40. (Pubitemid 32938548)
18. Hawighorst T, Oura H, Streit M, Janes L, Nguyen L, Brown LF, et al. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 2002;21:7945-56. (Pubitemid 35430606)
19. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci 1998;17:1-7. (Pubitemid 28253040)
20. Yuspa SH. Overview of carcinogenesis: past, present and future. Carcinogenesis 2000;21:341-4. (Pubitemid 30137918)
21. Ikushima H, Miyazono K. TGF-β signalling: a complex web in cancer progression. Nat Rev Cancer 2010;10:415-24.
22. Massague J. TGF-β in Cancer. Cell 2008;134:215-30.
23. Bierie B, Moses HL. Tumour microenvironment: TGF-β: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006;6:506-20. (Pubitemid 43980540)
24. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001;1:157-62. (Pubitemid 33741891)
25. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
26. Fearon ER, Vogelstein B.A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
27. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-81.
28. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990;61:1329-37.
29. Alam M, Ratner D. Cutaneous squamous-cell carcinoma.NEngl JMed 2001;344:975-83. (Pubitemid 32240317)